TNKASE Side Effects

6565661-X | Haemorrhage Intracranial
on Jan 27, 2010 Female patient from UNITED STATES , 61 years of age, weighting 129.9 lb, was diagnosed with ischaemic stroke and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial. Tnkase dosage: 30 Mg, Single.

6522409-2 | Atrioventricular Block Complete, Brain Stem Ischaemia, Cardio-respiratory Arrest, Cardiogenic Shock, Haemorrhagic Cerebral Infarction, Respiratory Failure, Treatment Failure, Ventricular Tachycardia
Patient was taking Tnkase (View Usage). Patient had the following side effects: atrioventricular block complete, brain stem ischaemia, cardio-respiratory arrest, cardiogenic shock, haemorrhagic cerebral infarction, respiratory failure, treatment failure, ventricular tachycardia on Dec 29, 2009 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 224.9 lb, was diagnosed with acute myocardial infarction and. Tnkase dosage: 50mg Once Iv Bolus. Patient was hospitalized.

6416824-5 | Haemorrhage Intracranial, Hydrocephalus
Adverse event was reported on Oct 22, 2009 by a Female patient taking Tnkase (View Usage) (Dosage: 7000 Unit, Single) . Location: CANADA , 73 years of age, weighting 132.3 lb, After Tnkase was administered, patient had the following side effects: haemorrhage intracranial, hydrocephalus (What is hydrocephalus?). During the same period patient was treated with CLOPIDOGREL BISULFATE (300 Mg, Single) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ENOXAPARIN SODIUM (90 Mg, Single) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6416823-3 | Haemorrhage Intracranial, Hemiparesis, Stupor
on Oct 22, 2009 Female patient from CANADA , 67 years of age, weighting 114.6 lb, was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial, hemiparesis, stupor. Tnkase dosage: 30 Mg, Single. During the same period patient was treated with HEPARIN (Unk) (View Heparin Review and Heparin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), NITROGLYCERIN (Unk) (View Nitroglycerin Review and Nitroglycerin Label ), LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ).


6293288-6 | Asthenia, Coronary Artery Stenosis, Dizziness, Ventricular Fibrillation
on Jul 21, 2009 Male patient from GERMANY , 75 years of age, was diagnosed with acute myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: asthenia, coronary artery stenosis, dizziness (What is dizziness?), ventricular fibrillation. Tnkase dosage: Unk, Unk.

6291328-1 | Haemorrhage Intracranial
Patient was taking Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: haemorrhage intracranial on Nov 17, 2008 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 158.1 lb, was diagnosed with myocardial infarction and. Tnkase dosage: 7 Ml, Single, Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6291320-7 | Arrhythmia
Adverse event was reported on Nov 13, 2008 by a Male patient taking Tnkase (View Usage) (Dosage: 45 Mg, Single, Intravenous) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?). During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), NITROGLYCERIN DRIP (NITROGLYCERIN) (View Nitroglycerin Drip (nitroglycerin) Review and Nitroglycerin Drip (nitroglycerin) Label ).

6291292-5 | Blood Pressure Systolic Decreased, Haematoma
on Aug 28, 2008 Male patient from UNITED STATES , 74 years of age, was diagnosed with acute myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: blood pressure systolic decreased, haematoma. Tnkase dosage: 35 Mg, Single. Patient was hospitalized.

6253486-4 | Cardiac Failure, Pulmonary Haemorrhage, Respiratory Failure
on Jun 25, 2009 Male patient from UNITED STATES , 71 years of age, was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cardiac failure, pulmonary haemorrhage, respiratory failure. Tnkase dosage: Unk.

6215793-0 | Haemorrhagic Stroke
Patient was taking Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic stroke on May 18, 2009 from GERMANY Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with acute myocardial infarction and. Tnkase dosage: 35 Mg, X1. During the same period patient was treated with CLOPIDOGREL (300 Mg, X1) (View Clopidogrel Review and Clopidogrel Label ), ENOXAPARIN SODIUM (100 Mg, X1) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6198797-6 | Cerebrovascular Accident
Adverse event was reported on May 13, 2009 by a Female patient taking Tnkase (View Usage) (Dosage: Unk) was diagnosed with acute myocardial infarction and. Location: GERMANY , weighting 154.3 lb, Patient had the following side effects: cerebrovascular accident. During the same period patient was treated with CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ), ENOXAPARIN SODIUM (Unk) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6172468-4 | Cardiogenic Shock, Heart Transplant
on Apr 21, 2009 Female patient from GERMANY , 43 years of age, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cardiogenic shock, heart transplant (What is heart transplant?). Tnkase dosage: Unk.

6129343-0 | Hypertension, Intracranial Haematoma, Unresponsive To Stimuli
on Mar 23, 2009 Female patient from UNITED STATES , 75 years of age, weighting 182.3 lb, was diagnosed with acute myocardial infarction and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, intracranial haematoma, unresponsive to stimuli. Tnkase dosage: 45 Mg Once Iv.

6120117-3 |
Patient was taking Tnkase (View Usage). on Mar 11, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with ischaemic stroke and. Tnkase dosage: Unk.

5804522-8 | Acute Myocardial Infarction, Brain Herniation, Cerebral Haemorrhage, Coronary Artery Disease, Lethargy, Nausea, Procedural Complication, Pupil Fixed, Unresponsive To Stimuli
Adverse event was reported on Jul 07, 2008 by a Male patient taking Tnkase (View Usage) (Dosage: 40 Mg Bolus Iv Bolus) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 69 years of age, weighting 172.0 lb, After Tnkase was administered, patient had the following side effects: acute myocardial infarction, brain herniation, cerebral haemorrhage, coronary artery disease (What is coronary artery disease?), lethargy, nausea (What is nausea?), procedural complication, pupil fixed, unresponsive to stimuli.

5368413-1 | Angioedema, Cardio-respiratory Arrest, Convulsion, Pulse Absent, Respiratory Distress, Ventricular Fibrillation
on Jun 22, 2007 Male patient from UNITED STATES , 52 years of age, was diagnosed with acute myocardial infarction and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, cardio-respiratory arrest, convulsion, pulse absent, respiratory distress, ventricular fibrillation. Tnkase dosage: 45mg One Time Iv Bolus.

5345549-2 | Cerebral Haemorrhage
on Jun 01, 2007 Female patient from UNITED STATES , weighting 211.6 lb, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: cerebral haemorrhage. Tnkase dosage: 50mg X1 Iv. During the same period patient was treated with HEPARIN (Drip) (View Heparin Review and Heparin Label ).

5248682-9 | Haemorrhagic Transformation Stroke
Patient was taking Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: haemorrhagic transformation stroke on Feb 26, 2007 from UNITED STATES Additional patient health information: Male patient , 71 years of age, . Tnkase dosage: 50 Mg Oto Iv. During the same period patient was treated with HEPARIN (Drip Iv) (View Heparin Review and Heparin Label ).

5230493-1 | Amnesia, Hemiparesis, Intraventricular Haemorrhage
Adverse event was reported on Jan 26, 2007 by a Female patient taking Tnkase (View Usage) (Dosage: Intravenous) . Location: CANADA , 70 years of age, weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: amnesia, hemiparesis, intraventricular haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE) (View Clopidogrel Bisulfate (clopidogrel Bisulfate) Review and Clopidogrel Bisulfate (clopidogrel Bisulfate) Label ), HEPARIN (View Heparin Review and Heparin Label ), METOPOLOL (METOPROLOL TARTRATE) (View Metopolol (metoprolol Tartrate) Review and Metopolol (metoprolol Tartrate) Label ).

5085489-X | Cardiogenic Shock, Cytolytic Hepatitis, Multi-organ Failure, Pneumonia
on Aug 03, 2006 Male patient from CANADA , 62 years of age, weighting 183.0 lb, was diagnosed with myocardial infarction, acute myocardial infarction, diagnostic procedure and was treated with Tnkase (View Usage). Patient had the following side effects: cardiogenic shock, cytolytic hepatitis, multi-organ failure, pneumonia (What is pneumonia?). Tnkase dosage: Single, Iv Bolus. During the same period patient was treated with ENOXAPARIN SODIUM (1 Mg/kg, Q12h, Subcutaneous) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), REOPRO (Iv Bolus; See Image) (View Reopro Review and Reopro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CONTRAST MEDIA NOS(RADIOPAQUE MEDIA NOS) (View Contrast Media Nos(radiopaque Media Nos) Review and Contrast Media Nos(radiopaque Media Nos) Label ).

5041293-X | Cerebral Haemorrhage, Overdose
on Jun 20, 2006 Female patient from UNITED STATES , 72 years of age, weighting 154.3 lb, was diagnosed with cerebrovascular accident and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cerebral haemorrhage, overdose. Tnkase dosage: See Image. During the same period patient was treated with ACTIVASE (See Image) (View Activase Review and Activase Label ).

5041271-0 | Cerebral Haemorrhage, Overdose
Patient was taking Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, overdose on Jun 20, 2006 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 154.3 lb, was diagnosed with cerebrovascular accident and. Tnkase dosage: See Image. During the same period patient was treated with ACTIVASE (7 Mg, Single, Iv Bolus) (View Activase Review and Activase Label ).

4967181-2 | Cerebral Haemorrhage, Overdose
Adverse event was reported on Mar 27, 2006 by a Female patient taking Tnkase (View Usage) (Dosage: See Image) was diagnosed with cerebrovascular accident and. Location: UNITED STATES , 72 years of age, weighting 154.3 lb, Patient had the following side effects: cerebral haemorrhage, overdose. During the same period patient was treated with ACTIVASE (See Image) (View Activase Review and Activase Label ).

4967163-0 | Cerebral Haemorrhage, Overdose
on Mar 27, 2006 Female patient from UNITED STATES , 72 years of age, weighting 154.3 lb, was diagnosed with cerebrovascular accident and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cerebral haemorrhage, overdose. Tnkase dosage: See Image. During the same period patient was treated with ACTIVASE (See Image) (View Activase Review and Activase Label ).

4942593-1 | Gastrointestinal Disorder
on Feb 24, 2006 Male patient from UNITED STATES , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder. Tnkase dosage: .

4854100-2 | Disease Progression, Ischaemia
Patient was taking Tnkase (View Usage). Patient had the following side effects: disease progression, ischaemia on Nov 30, 2005 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 145.5 lb, was diagnosed with ischaemic stroke and. Tnkase dosage: 50 Mg, Single, Intravenous.

4850682-5 | Brain Scan Abnormal, Cerebral Haemorrhage
Adverse event was reported on Dec 08, 2005 by a Male patient taking Tnkase (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: UNITED STATES , 51 years of age, After Tnkase was administered, patient had the following side effects: brain scan abnormal, cerebral haemorrhage. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

4740753-6 | Pulmonary Haemorrhage
on Apr 21, 2005 Female patient from UNITED STATES , 76 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary haemorrhage. Tnkase dosage: .

4740751-2 | Cerebral Haematoma, Cerebral Haemorrhage
on Feb 09, 2005 Male patient from UNITED STATES , 57 years of age, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: cerebral haematoma, cerebral haemorrhage. Tnkase dosage: 45 Mg, Single, Intravenous. During the same period patient was treated with NITROGLYCERIN DRIP (NITROGLYCERIN) (View Nitroglycerin Drip (nitroglycerin) Review and Nitroglycerin Drip (nitroglycerin) Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HEPARIN (View Heparin Review and Heparin Label ).

4740727-5 | Cerebral Haematoma
Patient was taking Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cerebral haematoma on Jan 10, 2005 from UNITED STATES Additional patient health information: Male patient , 44 years of age, was diagnosed with myocardial infarction and. Tnkase dosage: . During the same period patient was treated with INTEGRILIN (View Integrilin Review and Integrilin Label ), HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4740419-2 | Injection Site Haemorrhage
Adverse event was reported on Jun 07, 2004 by a Female patient taking Tnkase (View Usage) (Dosage: Single, Intravenous) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 81 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: injection site haemorrhage. During the same period patient was treated with DOPAMINE (DOPAMINE HYDROCHLORIDE) (View Dopamine (dopamine Hydrochloride) Review and Dopamine (dopamine Hydrochloride) Label ), HEPARIN (View Heparin Review and Heparin Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

4740418-0 | Pulmonary Haemorrhage
on Apr 21, 2005 Female patient from UNITED STATES , 76 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Tnkase (View Usage). Patient had the following side effects: pulmonary haemorrhage. Tnkase dosage: .

4740416-7 | Cerebral Haematoma, Cerebral Haemorrhage
on Feb 09, 2005 Male patient from UNITED STATES , 57 years of age, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cerebral haematoma, cerebral haemorrhage. Tnkase dosage: 45 Mg, Single, Intravenous. During the same period patient was treated with NITROGLYCERIN DRIP (NITROGLYCERIN) (View Nitroglycerin Drip (nitroglycerin) Review and Nitroglycerin Drip (nitroglycerin) Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HEPARIN (View Heparin Review and Heparin Label ).

4708498-6 | Cerebrovascular Accident
Patient was taking Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Jul 05, 2005 from UNITED STATES Additional patient health information: Female patient , child 5 years of age, weighting 156.0 lb, was diagnosed with cerebrovascular accident and. Tnkase dosage: 3 Mg Intraarterial.

4693810-7 | Cardiogenic Shock, Cytolytic Hepatitis, Gastric Haemorrhage, Multi-organ Failure, Pneumonia, Post Procedural Complication, Renal Failure Acute
Adverse event was reported on Jun 07, 2005 by a Male patient taking Tnkase (View Usage) (Dosage: Single, Iv Bolus) was diagnosed with myocardial infarction and. Location: , 62 years of age, weighting 183.0 lb, Patient had the following side effects: cardiogenic shock, cytolytic hepatitis, gastric haemorrhage, multi-organ failure, pneumonia (What is pneumonia?), post procedural complication, renal failure acute. During the same period patient was treated with ENOXAPARIN SODIUM (Iv Bolus) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ABCIXIMAB (ABCIXIMAB) (Intravenous; See Image) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ).

4688551-6 | Cardiogenic Shock, Cytolytic Hepatitis, Gastric Haemorrhage, Multi-organ Failure, Pneumonia, Renal Failure Acute
on May 10, 2005 Male patient from , 62 years of age, weighting 183.0 lb, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cardiogenic shock, cytolytic hepatitis, gastric haemorrhage, multi-organ failure, pneumonia (What is pneumonia?), renal failure acute. Tnkase dosage: Single, Iv Bolus. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ABCIXMAB (ABCIXMAB) (See Image) (View Abcixmab (abcixmab) Review and Abcixmab (abcixmab) Label ).

4645948-8 | Post Procedural Complication, Pulmonary Embolism, Pulmonary Haemorrhage
on Apr 22, 2005 Female patient from , 76 years of age, weighting 148.0 lb, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural complication, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage. Tnkase dosage: 5 Mg Infused Directly To Clot Site In Upper Lobe. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), ARGATROBAN (View Argatroban Review and Argatroban Label ).

4645480-1 | Atelectasis, Cardiogenic Shock, Culture Urine Positive, Cytolytic Hepatitis, Fatigue, Gastrointestinal Haemorrhage, Hyperthermia, Klebsiella Infection
Patient was taking Tnkase (View Usage). Patient had the following side effects: atelectasis, cardiogenic shock, culture urine positive, cytolytic hepatitis, fatigue, gastrointestinal haemorrhage, hyperthermia, klebsiella infection on Apr 19, 2005 from Additional patient health information: Male patient , 62 years of age, weighting 183.0 lb, was diagnosed with myocardial infarction and. Tnkase dosage: Single, Iv Bolus. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), LASIX (View Lasix Review and Lasix Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FESO4 (FERROUS SULFATE) (View Feso4 (ferrous Sulfate) Review and Feso4 (ferrous Sulfate) Label ), PENMIX (HUMAN) (INSULIN HUMAN, NPH HUMAN INSULIN ISOPHANE SUSPENSION) (View Penmix (human) (insulin Human, Nph Human Insulin Isophane Suspension) Review and Penmix (human) (insulin Human, Nph Human Insulin Isophane Suspension) Label ), PANTERIC (PANCREATIN) (View Panteric (pancreatin) Review and Panteric (pancreatin) Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

4638329-4 | Atelectasis, Cardiogenic Shock, Culture Urine Positive, Cytolytic Hepatitis, Fatigue, Hyperthermia, Klebsiella Infection, Multi-organ Failure
Adverse event was reported on Apr 07, 2005 by a Male patient taking Tnkase (View Usage) (Dosage: Single, Iv Bolus) was diagnosed with myocardial infarction and. Location: , 62 years of age, weighting 183.0 lb, After Tnkase was administered, patient had the following side effects: atelectasis, cardiogenic shock, culture urine positive, cytolytic hepatitis, fatigue, hyperthermia, klebsiella infection, multi-organ failure. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), LASIX (View Lasix Review and Lasix Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FES04 (FERROUS SULFATE) (View Fes04 (ferrous Sulfate) Review and Fes04 (ferrous Sulfate) Label ), PENMIX (HUMAN) (INSULIN HUMAN, NPH HUMAN INSULIN ISOPHANE SUSPENSION) (View Penmix (human) (insulin Human, Nph Human Insulin Isophane Suspension) Review and Penmix (human) (insulin Human, Nph Human Insulin Isophane Suspension) Label ), PANTERIC (PANCREATIN) (View Panteric (pancreatin) Review and Panteric (pancreatin) Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

4599809-3 | Anaemia, Pneumonia
on Feb 25, 2005 Female patient from , 77 years of age, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pneumonia (What is pneumonia?). Tnkase dosage: . During the same period patient was treated with ANTIBIOTIC NOS (ANTIBIOTIC NOS) (View Antibiotic Nos (antibiotic Nos) Review and Antibiotic Nos (antibiotic Nos) Label ).

4599641-0 | Anaemia, Pneumonia
on Feb 25, 2005 Female patient from , 77 years of age, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: anaemia, pneumonia (What is pneumonia?). Tnkase dosage: .

4596889-6 | Anaemia, Nosocomial Infection, Pneumonia
Patient was taking Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: anaemia, nosocomial infection, pneumonia (What is pneumonia?) on Jan 24, 2005 from Additional patient health information: Female patient , 77 years of age, was diagnosed with myocardial infarction and. Tnkase dosage: .

4596888-4 | Anaemia, Pneumonia
Adverse event was reported on Jan 24, 2005 by a Female patient taking Tnkase (View Usage) (Dosage: ) was diagnosed with myocardial infarction and. Location: , 77 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, pneumonia (What is pneumonia?). During the same period patient was treated with ANTIBIOTIC NOS (ANTIBIOTICS NOS) (View Antibiotic Nos (antibiotics Nos) Review and Antibiotic Nos (antibiotics Nos) Label ).

4595843-8 | Cardiogenic Shock, Cytolytic Hepatitis, Gastric Haemorrhage, Multi-organ Failure, Pneumonia, Renal Failure Acute
on Feb 15, 2005 Male patient from , 62 years of age, weighting 183.0 lb, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). Patient had the following side effects: cardiogenic shock, cytolytic hepatitis, gastric haemorrhage, multi-organ failure, pneumonia (What is pneumonia?), renal failure acute. Tnkase dosage: Single, Iv Bolus. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ABCIXIMAB (ABCIXIMAB) (Intravenous) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ).

4578763-4 | Cardio-respiratory Arrest, Cerebral Haematoma, Cerebral Haemorrhage, Coma, Headache, Nausea, Pupil Fixed
on Feb 07, 2005 Male patient from , 57 years of age, weighting 187.4 lb, was diagnosed with myocardial infarction and was treated with Tnkase (View Usage). After Tnkase was administered, patient had the following side effects: cardio-respiratory arrest, cerebral haematoma, cerebral haemorrhage, coma, headache (What is headache?), nausea (What is nausea?), pupil fixed. Tnkase dosage: 45mg Iv X 1. During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), INTEGRILIN (View Integrilin Review and Integrilin Label ), PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HEPARIN (View Heparin Review and Heparin Label ).